Atara Biotherap (ATRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,482 | 25,176 | 25,987 | 93,088 | 106,278 |
| Marketable Securities | N/A | 17,466 | 25,884 | 149,877 | 264,984 |
| Receivables | 1,253 | 1,482 | 34,108 | 40,221 | 986 |
| Inventories | N/A | 10,655 | 9,706 | 1,586 | N/A |
| Other current assets | 2,477 | 10,115 | 6,184 | 10,308 | 0 |
| TOTAL | $12,212 | $64,894 | $101,869 | $295,080 | $384,621 |
| Non-Current Assets | |||||
| PPE Net | 73 | 1,294 | 3,856 | 6,300 | 53,780 |
| Other Non-Current Assets | 7,950 | 42,910 | 59,779 | 75,040 | 29,726 |
| TOTAL | $8,023 | $44,204 | $63,635 | $81,340 | $83,506 |
| Total Assets | $20,235 | $109,098 | $165,504 | $376,420 | $468,127 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 127 | 4,367 | 3,684 | 6,871 | 17,368 |
| Accrued Expenses | 1,271 | 6,589 | 11,519 | 17,659 | 25,150 |
| Other current liabilities | 12,726 | 20,542 | 31,826 | 21,394 | 9,057 |
| TOTAL | $14,922 | $134,574 | $142,226 | $78,916 | $105,786 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 716 | 95,092 | 77,833 | 8,000 | 40,760 |
| Other Non-Current Liabilities | 43,815 | 71,807 | 84,947 | 93,864 | 27,019 |
| TOTAL | $43,815 | $71,807 | $122,509 | $170,864 | $82,727 |
| Total Liabilities | $58,737 | $206,381 | $264,735 | $249,780 | $188,513 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,178 | 5,859 | 4,774 | 3,837 | 3,724 |
| Common Shares | 1 | 1 | N/A | 10 | 9 |
| Retained earnings | -2,021,865 | -2,054,553 | -1,969,150 | -1,693,024 | -1,464,722 |
| Other shareholders' equity | 1 | 8 | -204 | -2,067 | -368 |
| TOTAL | $-38,502 | $-97,283 | $-99,231 | $126,640 | $279,614 |
| Total Liabilities And Equity | $20,235 | $109,098 | $165,504 | $376,420 | $468,127 |